Form 8-K - Current report:
SEC Accession No. 0001104659-23-034751
Filing Date
2023-03-21
Accepted
2023-03-21 09:24:14
Documents
14
Period of Report
2023-03-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310134d1_8k.htm   iXBRL 8-K 31732
2 EXHIBIT 99.1 tm2310134d1_ex99-1.htm EX-99.1 15627
  Complete submission text file 0001104659-23-034751.txt   291457

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20230320.xsd EX-101.SCH 3543
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20230320_def.xml EX-101.DEF 29195
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20230320_lab.xml EX-101.LAB 39041
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20230320_pre.xml EX-101.PRE 27398
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310134d1_8k_htm.xml XML 6484
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
JATT Acquisition Corp (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 23748094
SIC: 2836 Biological Products, (No Diagnostic Substances)